IMiDs are known to induce degradation of zinc-finger transcription factors in myeloma cells, like IKZF1 and IKZF3, and like SALL4 in embryonic stem cells, which is behind their therapeutic, but also teratogenic functions [40, 54]. The gene discussed is IKZF1; the disease is plasma cell myeloma.